HLA-Sensitised Kidney Transplant: Options When You Have Antibodies
Posted 16 Jul 2026 | Source:

Some people who need a kidney transplant face a particular challenge: their immune system has developed antibodies against the tissue types of other people, which makes finding a compatible donor more difficult and raises the risk of rejection. Such people are described as sensitised, or HLA-sensitised. While this situation is more complex, it is far from hopeless — there are now several approaches to enable transplantation for sensitised patients. This article explains what sensitisation means and what can be done about it.

What is HLA sensitisation?

The cells of our bodies carry a set of markers called human leukocyte antigens, or HLA, which the immune system uses to distinguish “self” from “foreign.” In transplantation, the recipient’s immune system examines the HLA of the donor kidney, and a closer match generally means a lower risk of rejection. Some people, through previous exposure to other people’s HLA, have developed antibodies against a range of HLA types. This exposure can come from a previous transplant, from blood transfusions, or, in women, from pregnancy. Having these antibodies is what is meant by being sensitised.

A sensitised person’s antibodies mean that a greater proportion of potential donors are unsuitable, because the recipient has antibodies against them that would attack the donor kidney. The more sensitised a person is — the broader the range of HLA types they have antibodies against — the harder it is to find a donor against whom they do not have antibodies, and the more challenging transplantation becomes. Highly sensitised patients have historically faced long waits and significant difficulty in finding a suitable transplant.

How sensitisation is assessed

Sensitisation is assessed through blood tests that detect and characterise the recipient’s HLA antibodies, determining which HLA types they react against and how strongly. A key test in transplantation is the crossmatch, which checks directly whether the recipient has antibodies against a specific potential donor; a positive crossmatch traditionally indicated that transplanting that donor’s kidney would be hazardous. Modern testing can characterise a person’s antibodies in detail, allowing the transplant team to understand the pattern of sensitisation and to identify which potential donors are more or less problematic. This detailed assessment is the foundation for planning how to achieve a successful transplant for a sensitised person.

Approaches to transplanting sensitised patients

Several approaches now exist to enable transplantation for sensitised patients, and the right one depends on the individual’s degree and pattern of sensitisation and their circumstances.

Finding a better-matched donor.

One approach is to seek a donor against whom the recipient does not have significant antibodies. For sensitised patients with a willing but incompatible donor, paired exchange, discussed in a separate article, can be particularly valuable, as it may allow them to be matched with a donor they are compatible with from another pair.

Desensitisation.

Another approach is desensitisation — treatment before and around the transplant to reduce the level of the problematic antibodies and modify the immune response, so that a transplant which would otherwise be too risky can proceed. This is conceptually similar to the preparation used in ABO-incompatible transplantation, but directed at HLA antibodies. Desensitisation allows some sensitised patients to receive a transplant from a donor against whom they previously had antibodies, after their antibody levels have been brought down sufficiently.

Specialised matching schemes.

For highly sensitised patients, specialised allocation and matching schemes within deceased donor programmes aim to identify suitable, well-matched kidneys, and broader pools and prioritisation can improve their chances of finding a compatible organ. The availability of such schemes varies by location.

The transplant team assesses which combination of these approaches offers the best path for a given sensitised patient, and the management is necessarily individualised and specialised.

What transplantation involves for sensitised patients

Transplanting a sensitised patient is more complex than a standard transplant and requires specialised assessment, careful planning, and often additional treatment before and after the transplant, as well as close monitoring afterwards for signs of rejection. Because sensitised patients are at higher risk of rejection, the immunosuppression and monitoring may be more intensive, and the team watches especially carefully for antibody-mediated rejection, intervening promptly if it arises. This is demanding but well-established work in experienced transplant centres, and it has enabled successful transplantation for many patients who were once considered very difficult or impossible to transplant. The involvement of a centre experienced in managing sensitised patients is important for the best outcomes.

A message of hope for sensitised patients

While being sensitised undoubtedly makes transplantation more challenging, the important message is that it is increasingly possible. The combination of detailed antibody assessment, desensitisation, paired exchange, and specialised matching has substantially improved the prospects for sensitised patients, many of whom can now be successfully transplanted where once they could not. Highly sensitised patients should not assume that transplantation is closed to them; rather, they should seek assessment by an experienced transplant team, who can determine which of the available approaches might enable a transplant in their case. The field has advanced considerably, and continues to do so, in favour of these once hard-to-transplant patients.

The takeaway

HLA sensitisation — having antibodies against other people’s tissue types, often from previous transplants, transfusions, or pregnancy — makes finding a compatible donor harder and raises the risk of rejection. But a range of modern approaches, including detailed antibody assessment, desensitisation, paired exchange, and specialised matching schemes, now enable transplantation for many sensitised patients who would once have been considered untransplantable. If you have been told you are sensitised or highly sensitised, an experienced transplant team can assess your situation and the options open to you. Sensitisation is a challenge, but increasingly a surmountable one.

Being sensitised makes transplantation more complex, but a range of options now exists. If you have been told you have antibodies that complicate transplant, an experienced transplant physician can explain your options. A video consultation is a convenient way to begin.